Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» systemic anaplastic large cell lymphoma
systemic anaplastic large cell lymphoma
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/2/13 - 11:43 am
Seattle Genetics
Adcetris
T-cell lymphoma
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
Takeda seeks Japanese approval for brentuximab vedotin to treat relapsed/refractory CD30 positive HL and ALCL
Pharmabiz
Sat, 03/23/13 - 10:15 am
Takeda
brentuximab vedotin
systemic anaplastic large cell lymphoma
Seattle Genetics: A Cancer Niche Too Small
TheStreet.com
Mon, 03/5/12 - 11:11 am
Seattle Genetics
Adcetris
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
Seattle Genetics Announces FDA Accelerated Approval of ADCETRIS™ (Brentuximab Vedotin) for Two Indications
Yahoo/BusinessWire
Sat, 08/20/11 - 09:57 pm
systemic anaplastic large cell lymphoma
lymphoma
Hodgkin's lymphoma
Adcetris
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Enhanced Online News
Sat, 06/11/11 - 10:58 am
systemic anaplastic large cell lymphoma
Seattle Genetics
Millennium
Adcetris
